NCT02224066 - Platelet Reactivity After TAVI: A Multicenter Pilot Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

May 31, 2017

Study Completion Date

August 31, 2018

Conditions

Severe Aortic Valve StenosisTranscatheter Aortic Valve ImplantationTranscatheter Aortic Valve Replacement

Interventions

DRUG

Ticagrelor 90 mg twice per day during three months following TAVI

DRUG

Aspirin 100 mg plus Clopidogrel 75 mg daily during three months following TAVI

Trial Locations (7)

Hospital Virgen de las Nieves, Granada

Hospital Universitario La Paz, Madrid

Hospital Universitario Virgen de la Arrixaca, Murcia

Hospital Universitario Álvaro Cunqueiro, Vigo

Hospital Universitario de Salamanca, Salamanca

Hospital Clinic Universitari Bellvitge, L'Hospitalet de Llobregat

Hospital Santa Creu i Sant Creu, Barcelona

All Listed Sponsors

lead

Hospital de Meixoeiro

OTHER_GOV